Literature DB >> 3150023

Antibodies to the capsular polysaccharide of Neisseria meningitidis group B or E. coli K1 bind to the brains of infant rats in vitro but not in vivo.

K Saukkonen1, M Haltia, M Frosch, D Bitter-Süerman, M Leinonen.   

Abstract

The binding of monoclonal and polyclonal IgG antibodies specific to the capsular polysaccharide of Neisseria meningitidis group B and E. coli K1 was tested to the cross-reacting polysialosyl structures previously shown to be present in the brain of infant rats (Lancet 1983; ii: 355-7). Strong immunofluorescence was obtained after in vitro incubation of the brains of 1 to 13 days old rats with the antibodies whereas the brains of adult rats remained negative. The number of antibody-binding structures decreased as a function of age, being highest at the age of 1 to 5 days. However, when the same antibodies were injected intraperitoneally into the infant rat, or into the mother rat 2 days before parturition, no binding of antibodies to the infant rat brain tissue was observed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3150023     DOI: 10.1016/0882-4010(86)90036-7

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  7 in total

1.  Preclinical evaluation of group B Neisseria meningitidis and Escherichia coli K92 capsular polysaccharide-protein conjugate vaccines in juvenile rhesus monkeys.

Authors:  S J Devi; W D Zollinger; P J Snoy; J Y Tai; P Costantini; F Norelli; R Rappuoli; C E Frasch
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

Review 2.  Monoclonal antibodies to polysialic acid reveal epitope sharing between invasive pathogenic bacteria, differentiating cells and tumor cells.

Authors:  D Bitter-Suermann; J Roth
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

3.  The β-reducing end in α(2-8)-polysialic acid constitutes a unique structural motif.

Authors:  Hugo F Azurmendi; Marcos D Battistel; Jasmin Zarb; Flora Lichaa; Alejandro Negrete Virgen; Joseph Shiloach; Darón I Freedberg
Journal:  Glycobiology       Date:  2017-09-01       Impact factor: 4.313

4.  Capsular polysaccharide vaccine for Group B Neisseria meningitidis, Escherichia coli K1, and Pasteurella haemolytica A2.

Authors:  John B Robbins; Rachel Schneerson; Guilin Xie; Lars Å Hanson; Lars Åke-Hanson; Mark A Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-24       Impact factor: 11.205

5.  Antibodies to poly[(2----8)-alpha-N-acetylneuraminic acid] and poly[(2----9)-alpha-N-acetylneuraminic acid] are elicited by immunization of mice with Escherichia coli K92 conjugates: potential vaccines for groups B and C meningococci and E. coli K1.

Authors:  S J Devi; J B Robbins; R Schneerson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

6.  Extracellular structure of polysialic acid explored by on cell solution NMR.

Authors:  Hugo F Azurmendi; Justine Vionnet; Lauren Wrightson; Loc B Trinh; Joseph Shiloach; Darón I Freedberg
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-03       Impact factor: 11.205

7.  N-propionylated group B meningococcal polysaccharide mimics a unique epitope on group B Neisseria meningitidis.

Authors:  H J Jennings; A Gamian; F E Ashton
Journal:  J Exp Med       Date:  1987-04-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.